TCGplayer Links February Lutri and Biorhythm Unbans to Price Spikes

TCGplayer’s Seller Blog linked rapid secondary‑market swings to the Commander Format Panel’s Feb. 9 changes, and the analysis published on February 24, 2026 names Lutri, the Spellchaser and Biorhythm as the immediate drivers of volatility. TCGplayer ranks Biorhythm as its #1 mover and flags scarce printings of Lutri - Multiverse Legends bonus sheet, Foil Etched, and Halo Foil - as especially vulnerable to sudden listing squeezes.

The Format Panel’s change on February 9 unbanned Lutri for Commander use while retaining its companion ban, a nuance Seller TCGplayer and Saffron Olive both highlighted. Saffron Olive reported that “Lutri, the Spellchaser was unbanned (although it remains banned as a companion), causing it to shoot up more than 1,000% to $6.” Seller TCGplayer further notes specific Lutri foil and alternate printings crowded the movers list.

Biorhythm’s trajectory illustrated the rumor-then-peak pattern. Saffron Olive put the card at a threefold jump to $40, while Seller TCGplayer says Onslaught Biorhythm was “hovering under $10 before the announcement, but spiked immediately to almost $50,” with cheaper listings still visible under $30. Beckett’s market snapshot shows the classic unban cooling effect: “Biorhythm was the talk of the town following the February 9 Banned and Restricted announcement... It immediately spiked from $10 to nearly $50, but we are now seeing the inevitable unban cooling effect. This week, the price dropped to around $18.”

Speculation spread beyond the explicitly unbanned cards. Seller TCGplayer placed Griselbrand (Showcase) at #2 among movers and documented the speculative jump: “Griselbrand was not touched by February 9th’s Commander changes, or even mentioned in WotC’s accompanying article. But that didn’t stop speculators from deciding that if Biorhythm and Lutri could come off the Commander ban list, Griselbrand might too some day, and they might as well be prepared. In a little self-fulfilling prophecy, their certainty that Griselbrand would spike one day caused Griselbrand to spike immediately.” Mtggoldfish captured other concrete moves tied to the same period, reporting Primeval Titan climbed around 150% to $24, Dockside Extortionist (borderless) doubled to $45, and Iona, Shield of Emeria gained 173% to $15, noting Wizards had specifically mentioned Iona in their article.

Not every outlet recorded the same peak numbers. Mtggoldfish says Prophet of Kruphix “jumped 2.5x to $8,” while Evrimagaci, citing MTGstocks and The Economic Times, reported Prophet “skyrocketed an astonishing 428%.” Evrimagaci also lists Sylvan Primordial with a 353% spike and quotes The Economic Times that “The swing in resources can be huge, making it a terrifying inclusion for green Commander strategies.” Those divergent snapshots reflect different momentary peaks during the rumor frenzy around Feb. 9.

Set context and licensed products amplified pressure on specific cards. Saffron Olive ties Gilt-Leaf Palace’s more‑than‑double move to $15 to Lorwyn Eclipsed legends Maralen, Fae Ascendant and High Perfect Morcant, and argues a near‑term reprint was unlikely. Beckett connects Treebeard’s rise from $2 to over $7 to the new Doran stompy shell and calls Hancock, Ghoulish Mayor’s jump from about $2 to nearly $9 a product of limited Fallout set supply and IP demand, noting some versions rose “by over 1,000 percent.”

The clearest market lesson is summed up by Mtggoldfish: “The important lesson here is that speculating on ban list updates is risky. If you picked correctly and only bought Lutri, the Spellchaser and Biorhythm, you came out ahead, but if you bought other cards as well, it was likely a losing endeavor.” Multiple outlets record that many prices retreated from peak levels once the dust settled, leaving a mid‑February price map marked by sharp peaks, selective winners, and ongoing corrections.